AGOSTINO, RITA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 326
EU - Europa 236
AS - Asia 91
Totale 653
Nazione #
US - Stati Uniti d'America 324
IE - Irlanda 89
SE - Svezia 70
CN - Cina 66
IT - Italia 31
DE - Germania 16
HK - Hong Kong 13
FI - Finlandia 8
FR - Francia 8
BE - Belgio 6
IN - India 6
SG - Singapore 5
CA - Canada 2
CZ - Repubblica Ceca 2
ES - Italia 2
NL - Olanda 2
AL - Albania 1
JP - Giappone 1
UA - Ucraina 1
Totale 653
Città #
Chandler 97
Dublin 89
Nyköping 45
Ann Arbor 22
Beijing 22
New York 22
Ashburn 20
Dearborn 15
Princeton 14
Messina 13
Jacksonville 12
Medford 11
Boardman 10
Bremen 8
Des Moines 8
Cambridge 7
Nanjing 7
Brussels 6
Munich 6
Seattle 6
Pune 5
Shenyang 5
Zhengzhou 5
Hangzhou 4
Helsinki 4
Sheung Shui 4
Central 3
Houston 3
Jinan 3
Los Angeles 3
San Mateo 3
Singapore 3
Amsterdam 2
Changsha 2
Córdoba 2
Fiumefreddo Di Sicilia 2
Fuzhou 2
Guangzhou 2
Hebei 2
Milan 2
Nanchang 2
Riva 2
Wilmington 2
Brno 1
Changle 1
Clearwater 1
Haikou 1
Hyderabad 1
Limeil-brévannes 1
Matawan 1
Milazzo 1
Ningbo 1
Olomouc 1
Pisa 1
San Francisco 1
Strasbourg 1
Taizhou 1
Tappahannock 1
Tianjin 1
Totale 523
Nome #
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 83
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 75
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 67
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 66
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 60
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 59
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 59
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 58
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 57
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 48
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 44
Totale 676
Categoria #
all - tutte 2.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 3 2 2 1 15 12 5 5 19 3 0
2020/202160 6 1 25 4 9 1 1 1 0 9 2 1
2021/202297 1 9 4 4 2 0 10 3 6 15 9 34
2022/2023288 22 38 12 27 19 33 1 19 106 1 7 3
2023/202498 5 10 3 9 3 30 3 21 0 1 1 12
2024/202523 10 13 0 0 0 0 0 0 0 0 0 0
Totale 676